{"schema_version":"1","generated_at":"2026-11-02T21:48:26.621Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/aram-modrek","json_url":"https://www.findmykol.com/kol/aram-modrek/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"aram-modrek","name":"Aram Modrek","credential":"MD","title":"Radiation oncologist, USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC; Assistant Professor of Radiation Oncology","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia"],"institution":"Keck School of Medicine of USC","institution_url":"https://www.findmykol.com/institution/keck-school-of-medicine-of-usc","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1215427695","orcid":"0000-0001-7586-9833","openalex":"A5022489726"},"summary":"Aram Modrek is Radiation oncologist, USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC; Assistant Professor of Radiation Oncology at Keck School of Medicine of USC. OpenAlex indexes 62 publications with 1,228 citations (h-index 15).","overview":{"text":"Aram Sandaldjian Modrek, MD, PHD, is Radiation oncologist, USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC at Keck School of Medicine of USC (Keck Medicine of USC). The public record shows 62 publications with 1,228 citations (h-index 15), centered on Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Cancer Cells and Metastasis. It also documents industry payments reported by 1 companies, 1 NIH-funded awards (2023–2026).","bullets":["Most recent indexed publication: 2026 · Cancers","Top research focus: Glioma Diagnosis and Treatment","Open Payments reporting from 1 companies"],"generated_at":"2026-11-02"},"focus":{"indications":[{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Cancer, Hypoxia, and Metabolism","Cancer Cells and Metastasis","Epigenetics and DNA Methylation","Acute Myeloid Leukemia Research"],"works_with":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Novocure Inc.","trials":0,"payments":2,"mentions":2}]}},"scholarship":{"works_count":62,"cited_by_count":1228,"h_index":15,"i10_index":18,"pubmed_count":7,"latest_activity_year":2026,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2024,"last":2025},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Novocure Inc.","program_year":2025,"amount_usd":23.87,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215427695"},{"payer":"Novocure Inc.","program_year":2024,"amount_usd":27.17,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215427695"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215427695","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2023,"last":2026},"rows_total":5,"shown":3,"withheld":2,"rows":[{"project":"K08CA263302","title":"Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma","fiscal_year":2026,"amount_usd":142007,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/K08CA263302"},{"project":"K08CA263302","title":"Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma","fiscal_year":2025,"amount_usd":142007,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/K08CA263302"},{"project":"K08CA263302","title":"Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma","fiscal_year":2024,"amount_usd":142007,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/K08CA263302"}],"source":"grants"},"congress":{"count":11,"years":{"first":2013,"last":2026},"societies":["AACR","ASTRO"],"shown":3,"withheld":8,"rows":[{"title":"Abstract 1950: Integrated transcriptomic and epigenomic analysis to study the mechanism by which smoke-induced hypomethylation of cg05575921 increases lung cancer risk.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1950","source_url":"https://doi.org/10.1158/1538-7445.am2026-1950","status":"verified"},{"title":"Abstract 7376: HMGB2-mediated radioresistance of glioblastoma stem cells","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-7376","source_url":"https://doi.org/10.1158/1538-7445.am2026-7376","status":"verified"},{"title":"Abstract 2819: Genome-wide CRISPR screen identifies NANP as a radio-sensitizing target of GBM by regulating NF-κB pathway","society":"AACR","meeting":"AACR Annual Meeting","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2023-2819","source_url":"https://doi.org/10.1158/1538-7445.am2023-2819","status":"verified"}],"source":"congress"},"publications":{"total":7,"shown":5,"withheld":2,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"GammaTile(®) Brachytherapy as Spatially Fractionated Radiation Therapy for Postoperative Brain Cancer: A Paradigm for Precision Intracranial Radiotherapy.","year":2026,"journal":"Cancers","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42882895/","status":"verified"},{"title":"Persistent chromatin alterations and gene expression reprogramming follow widespread DNA damage in glioblastoma.","year":2026,"journal":"Nature communications","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42811032/","status":"verified"},{"title":"NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift.","year":2026,"journal":"Nature communications","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41851195/","status":"verified"},{"title":"Single-Cell Multiomic Profiling Uncovers Radiation Dosage-Sensitive, Cluster-Specific Regulatory Dynamics in Glioblastoma.","year":2025,"journal":"bioRxiv : the preprint server for biology","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41573875/","status":"verified"},{"title":"Persistent chromatin alterations and gene expression reprogramming follow widespread DNA damage in glioblastoma.","year":2025,"journal":"bioRxiv : the preprint server for biology","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40667295/","status":"verified"}],"most_cited":{"total":62,"shown":5,"withheld":57,"rows":[{"title":"Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics","year":2019,"cited_by_count":229,"type":"review","source_url":"https://doi.org/10.3389/fonc.2019.00417"},{"title":"Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma","year":2018,"cited_by_count":191,"type":"article","source_url":"https://doi.org/10.1126/sciadv.aau5935"},{"title":"Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2","year":2017,"cited_by_count":117,"type":"article","source_url":"https://doi.org/10.1016/j.celrep.2017.10.009"},{"title":"Brain stem cells as the cell of origin in glioma","year":2014,"cited_by_count":91,"type":"article","source_url":"https://doi.org/10.4252/wjsc.v6.i1.43"},{"title":"Targeting Tumor Suppressor Networks for Cancer Therapeutics","year":2014,"cited_by_count":82,"type":"article","source_url":"https://doi.org/10.2174/1389450114666140106095151"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Dimitris G. Placantonakis","coauthored_works":23},{"name":"Erik P. Sulman","coauthored_works":22},{"name":"Ravesanker Ezhilarasan","coauthored_works":17}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/aram-modrek-md","status":"provisional"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://med.nyu.edu/faculty/aram-s-modrek","platform":"other","status":"provisional"},{"url":"https://www.keckmedicine.org/provider/aram-sandaldjian-modrek/","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, New York University","source_url":"https://med.nyu.edu/faculty/aram-s-modrek","status":"provisional","collected_at":"2026-11-02"},{"value":"PhD, New York University","source_url":"https://med.nyu.edu/faculty/aram-s-modrek","status":"provisional","collected_at":"2026-11-02"}]},"roles":{"total":5,"shown":3,"rows":[{"value":"Member, Society for Neuro-Oncology","source_url":"https://ent.keckmedicine.org/?p=109720","status":"provisional","collected_at":"2026-11-02"},{"value":"Member, American Association for Cancer Research","source_url":"https://ent.keckmedicine.org/?p=109720","status":"provisional","collected_at":"2026-11-02"},{"value":"Member, American Society for Radiation Oncology","source_url":"https://ent.keckmedicine.org/?p=109720","status":"provisional","collected_at":"2026-11-02"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"V Foundation Scholar Award ($600,000), glioblastoma treatment escape research","source_url":"https://oncodaily.com/blog/146396","status":"provisional","collected_at":"2026-11-02"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"New York University Grossman School of Medicine, Research Assistant Professor, Department of Radiation Oncology (past, per NYU profile)","source_url":"https://med.nyu.edu/faculty/aram-s-modrek","status":"provisional","collected_at":"2026-11-02"}]}},"similar":[{"name":"Norah Terrault","slug":"norah-terrault","institution":"Keck School of Medicine of USC","specialty":"Transplant Hepatology","url":"https://www.findmykol.com/kol/norah-terrault","json_url":"https://www.findmykol.com/kol/norah-terrault/profile.json"},{"name":"John Ringman","slug":"john-ringman","institution":"Keck School of Medicine of USC","specialty":"Neurology","url":"https://www.findmykol.com/kol/john-ringman","json_url":"https://www.findmykol.com/kol/john-ringman/profile.json"},{"name":"Leslie Saxon","slug":"leslie-saxon","institution":"Keck School of Medicine of USC","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/leslie-saxon","json_url":"https://www.findmykol.com/kol/leslie-saxon/profile.json"},{"name":"William Stohl","slug":"william-stohl","institution":"Keck School of Medicine of USC","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/william-stohl","json_url":"https://www.findmykol.com/kol/william-stohl/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":2,"congress":8,"publications":2,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-02"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2024 to 2025","collected_at":"2026-11-02"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-02"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-02"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-02"}},"methodology_url":"https://www.findmykol.com/about#methodology"}